epoetin alfa
UkraineDrugs containing this active substance
-
The drug is used to treat anemia caused by chronic kidney disease (in adults and children on dialysis or peritoneal dialysis), as well as anemia in patients receiving chemotherapy for tumors. It is also used to increase autologous blood volume before surgery and in certain forms of myelodysplastic syndrome.
Form: solution for injection
Active substance Dosage epoetin alfa 84 mcg/ml ATC: B03XA01
Manufacturer: Sandoz GmbH - BP Schaftlern (Responsible for batch release)
-
The drug is used to treat anemia caused by chronic renal failure (in adults and children), as well as anemia in patients undergoing chemotherapy for malignant neoplasms. It is also used to increase autologous blood volume before surgical operations and in certain types of myelodysplastic syndromes.
Form: solution for injection
Active substance Dosage epoetin alfa 16.8 mcg/ml or 2000 IU/ml ATC: B03XA01
Manufacturer: Sandoz GmbH - BP Schaftlern (Responsible for batch release)
-
The drug is used to treat anemia caused by chronic renal failure (in adults and children), as well as anemia in patients undergoing chemotherapy for malignant neoplasms. It is also used for preoperative preparation (autologous blood collection) and in certain types of myelodysplastic syndromes.
Form: solution for injection
Active substance Dosage epoetin alfa 336 mcg/ml ATC: B03XA01
Manufacturer: Sandoz GmbH - BP Schaftlern (Responsible for batch release)
-
The drug is used to treat anemia associated with chronic kidney disease (in adults and children on dialysis), as well as anemia in patients undergoing chemotherapy for tumors or lymphomas. It is also used to facilitate autologous blood collection before surgery and in certain types of blood disorders (MDS).
Form: lyophilisate for solution for injection
Active substance Dosage epoetin alfa 1000 IU ATC: B03XA01
Manufacturer: Biosidus S.A. (manufacturing of unpackaged product, primary and secondary packaging; quality control, batch release)
-
The drug is used to treat anemia associated with chronic kidney disease (in adults and children on dialysis or non-dialysis) as well as anemia in patients undergoing chemotherapy for tumors, lymphomas, or myeloma. It is also used to facilitate autologous blood collection before surgery and for patients with certain types of bone marrow disorders (MDS).
Form: lyophilisate for solution for injection
Active substance Dosage epoetin alfa 2000 IU ATC: B03XA01
Manufacturer: Biosidus S.A. (manufacturing of unpackaged product, primary and secondary packaging; quality control, batch release)
-
The drug is used to treat anemia associated with chronic kidney disease (in adults and children on dialysis or without dialysis), as well as anemia in patients undergoing chemotherapy for tumors, lymphomas, or myeloma. It is also used to facilitate autologous blood collection before surgery and in certain types of blood disorders (MDS).
Form: lyophilisate for solution for injection
Active substance Dosage epoetin alfa 3000 IU ATC: B03XA01
Manufacturer: Biosidus S.A. (manufacturing of unpackaged product, primary and secondary packaging; quality control, batch release)
-
The drug is used to treat anemia associated with chronic kidney disease (in adults and children on dialysis or without dialysis), as well as anemia caused by chemotherapy in oncological diseases. It is also used to facilitate autologous blood collection in patients before surgery and in certain types of bone marrow disorders (MDS).
Form: lyophilisate for solution for injection
Active substance Dosage epoetin alfa 4000 IU ATC: B03XA01
Manufacturer: Biosidus S.A. (manufacturing of unpackaged product, primary and secondary packaging; quality control, batch release)
-
The drug is used to treat anemia associated with chronic kidney disease (in adults and children on dialysis), as well as anemia in patients undergoing chemotherapy for tumors, lymphomas, or myeloma. It is also used to facilitate autologous blood collection before surgery and in certain hematological disorders (MDS).
Form: lyophilisate for solution for injection
Active substance Dosage epoetin alfa 10 000 IU ATC: B03XA01
Manufacturer: Biosidus S.A. (manufacturing of unpackaged product, primary and secondary packaging; quality control, batch release)
-
The drug is used to treat anemia associated with chronic kidney disease (in adults and children on dialysis or non-dialysis) as well as anemia in patients undergoing chemotherapy for tumors or lymphomas. It is also used to facilitate autologous blood collection before surgery and in certain types of bone marrow disorders (MDS).
Form: lyophilisate for solution for injection
Active substance Dosage epoetin alfa 20000 IU ATC: B03XA01
Manufacturer: Biosidus S.A. (manufacturing of unpackaged product, primary and secondary packaging; quality control, batch release)
-
The drug is used to treat anemia associated with chronic kidney disease (in adults and children on dialysis or non-dialysis) as well as anemia in patients undergoing chemotherapy for tumors, lymphomas, or myeloma. It is also used to facilitate autologous blood collection before surgery and in certain hematological diseases (MDS).
Form: lyophilisate for solution for injection
Active substance Dosage epoetin alfa 40 000 IU ATC: B03XA01
Manufacturer: Biosidus S.A. (manufacturing of unpackaged product, primary and secondary packaging; quality control, batch release)